Cargando…

The burden of insomnia in Japan

OBJECTIVES: Several studies have suggested that patients who experience insomnia report a number of significant impairments. However, despite this literature, fewer studies have focused on the burden of insomnia among patients in Japan. The objective of the current study is to extend this work in Ja...

Descripción completa

Detalles Bibliográficos
Autores principales: Mishima, Kazuo, DiBonaventura, Marco daCosta, Gross, Hillary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4293931/
https://www.ncbi.nlm.nih.gov/pubmed/25610008
http://dx.doi.org/10.2147/NSS.S73437
_version_ 1782352677833801728
author Mishima, Kazuo
DiBonaventura, Marco daCosta
Gross, Hillary
author_facet Mishima, Kazuo
DiBonaventura, Marco daCosta
Gross, Hillary
author_sort Mishima, Kazuo
collection PubMed
description OBJECTIVES: Several studies have suggested that patients who experience insomnia report a number of significant impairments. However, despite this literature, fewer studies have focused on the burden of insomnia among patients in Japan. The objective of the current study is to extend this work in Japan to further understand the effect of insomnia on health-related quality of life (hrQOL). Further, another objective is to understand general predictors of hrQOL among patients with insomnia. METHODS: Data from the 2012 Japan National Health and Wellness Survey, an annual, cross-sectional study of adults aged 18 years or older, were used (N=30,000). All National Health and Wellness Survey respondents were categorized based on the incidence of self-reported insomnia diagnosis and prescription medication usage (clinical insomniacs under treatment versus [vs] good sleepers without insomnia or insomnia symptoms). Comparisons among different groups were made using multiple regression models controlling for demographics and health history. RESULTS: Clinical insomniacs (n=1,018; 3.4%) reported significantly worse hrQOL compared with good sleepers (n=20,542) (mental component summary: 34.2 vs 48.0; physical component summary: 48.0 vs 52.8; health utilities: 0.61 vs 0.76; all P<0.05). Health behaviors (smoking, exercise, alcohol use) and comorbidities were the strongest predictors of health utilities for clinical insomniacs. For all three clinical insomniac subgroups of interest, those with a physical comorbidity but not a psychiatric one, those with a psychiatric comorbidity but not a physical one, and those without either a physical or psychiatric comorbidity, large decrements in health utilities were observed for respondents who did not engage in any positive health behaviors (0.61, 0.57, 0.64, respectively) relative to good sleepers (0.78). However, the gap in health utility scores between these subgroups and good sleepers diminishes with an increasing number of positive health behaviors (eg, clinical insomniacs with a physical comorbidity but not a psychiatric comorbidity performing all three positive health behaviors =0.67 vs good sleepers =0.78). DISCUSSION: A significant burden remains for those with insomnia who are treated. Given the particularly low levels of hrQOL among treated insomnia patients who have poor health behavior profiles and have psychiatric comorbidities, physicians should place particular emphasis on these patients who are most in need of intervention. Improved treatments may help to address the unmet needs of these patient populations.
format Online
Article
Text
id pubmed-4293931
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-42939312015-01-21 The burden of insomnia in Japan Mishima, Kazuo DiBonaventura, Marco daCosta Gross, Hillary Nat Sci Sleep Original Research OBJECTIVES: Several studies have suggested that patients who experience insomnia report a number of significant impairments. However, despite this literature, fewer studies have focused on the burden of insomnia among patients in Japan. The objective of the current study is to extend this work in Japan to further understand the effect of insomnia on health-related quality of life (hrQOL). Further, another objective is to understand general predictors of hrQOL among patients with insomnia. METHODS: Data from the 2012 Japan National Health and Wellness Survey, an annual, cross-sectional study of adults aged 18 years or older, were used (N=30,000). All National Health and Wellness Survey respondents were categorized based on the incidence of self-reported insomnia diagnosis and prescription medication usage (clinical insomniacs under treatment versus [vs] good sleepers without insomnia or insomnia symptoms). Comparisons among different groups were made using multiple regression models controlling for demographics and health history. RESULTS: Clinical insomniacs (n=1,018; 3.4%) reported significantly worse hrQOL compared with good sleepers (n=20,542) (mental component summary: 34.2 vs 48.0; physical component summary: 48.0 vs 52.8; health utilities: 0.61 vs 0.76; all P<0.05). Health behaviors (smoking, exercise, alcohol use) and comorbidities were the strongest predictors of health utilities for clinical insomniacs. For all three clinical insomniac subgroups of interest, those with a physical comorbidity but not a psychiatric one, those with a psychiatric comorbidity but not a physical one, and those without either a physical or psychiatric comorbidity, large decrements in health utilities were observed for respondents who did not engage in any positive health behaviors (0.61, 0.57, 0.64, respectively) relative to good sleepers (0.78). However, the gap in health utility scores between these subgroups and good sleepers diminishes with an increasing number of positive health behaviors (eg, clinical insomniacs with a physical comorbidity but not a psychiatric comorbidity performing all three positive health behaviors =0.67 vs good sleepers =0.78). DISCUSSION: A significant burden remains for those with insomnia who are treated. Given the particularly low levels of hrQOL among treated insomnia patients who have poor health behavior profiles and have psychiatric comorbidities, physicians should place particular emphasis on these patients who are most in need of intervention. Improved treatments may help to address the unmet needs of these patient populations. Dove Medical Press 2015-01-05 /pmc/articles/PMC4293931/ /pubmed/25610008 http://dx.doi.org/10.2147/NSS.S73437 Text en © 2015 Mishima et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Mishima, Kazuo
DiBonaventura, Marco daCosta
Gross, Hillary
The burden of insomnia in Japan
title The burden of insomnia in Japan
title_full The burden of insomnia in Japan
title_fullStr The burden of insomnia in Japan
title_full_unstemmed The burden of insomnia in Japan
title_short The burden of insomnia in Japan
title_sort burden of insomnia in japan
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4293931/
https://www.ncbi.nlm.nih.gov/pubmed/25610008
http://dx.doi.org/10.2147/NSS.S73437
work_keys_str_mv AT mishimakazuo theburdenofinsomniainjapan
AT dibonaventuramarcodacosta theburdenofinsomniainjapan
AT grosshillary theburdenofinsomniainjapan
AT mishimakazuo burdenofinsomniainjapan
AT dibonaventuramarcodacosta burdenofinsomniainjapan
AT grosshillary burdenofinsomniainjapan